Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-14-022042
Filing Date
2014-03-19
Accepted
2014-03-19 21:51:43
Documents
2
Period of Report
2014-03-19

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 8316
2 EX-24 DOCUMENT attachment1.htm EX-24 34248
  Complete submission text file 0001209191-14-022042.txt   44427
Mailing Address 505 South Rosa Road Madison WI 53719
Business Address 505 South Rosa Road Madison WI 53719 (608) 441-2700
Venture Investors Early Stage Fund IV LP (Reporting) CIK: 0001412729 (see all company filings)

State of Incorp.: DE
Type: 3 | Act: 34 | File No.: 001-36352 | Film No.: 14705416

Mailing Address 245 FIRST STREET SUITE 1100 CAMBRIDGE MA 02142
Business Address 245 FIRST STREET SUITE 1100 CAMBRIDGE MA 02142 617-871-2098
Akebia Therapeutics, Inc. (Issuer) CIK: 0001517022 (see all company filings)

IRS No.: 208756903 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 505 SOUTH ROSA ROAD, SUITE 201 MADISON WI 53719
Business Address
Ganser Roger H (Reporting) CIK: 0001602994 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36352 | Film No.: 14705415